FDA Pauses Authorization Of Eli Lilly’s COVID-19 Monoclonal Antibody Treatment Bebtelovimab

Reuters (11/30, Leo) reports, “Eli Lilly and Co’s COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, the Food and Drug Administration said, citing it is not expected to neutralize the dominant BQ.1 and BQ.1.1 su...